Coffee shop chain Baresso expanding in Denmark

The company plans to open 30 new locations over the next three years

The Danish chain of coffee shops Baresso has announced plans to open 30 new coffee bars in the next three years.

The chain will almost double the number of its cafes thanks to a financial boost from a new owner, the German investment firm Jab Holding.

Already this year, Baresso, which currently runs 35 coffee bars, plans to open 11-13 new cafes both in big cities and small towns across Denmark.

In 2015, Baresso increased its revenue by 10 percent, but ended with a loss of 4.6 million kroner due to the costs associated with the company’s sale.

Jab Holding also owns the Swedish coffee shop chain Espresso House – a chain of  200 cafes in Sweden, Norway and Finland that will open its first in Denmark this spring at Rådhuspladsen in Copenhagen.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.